Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31)

Current Opinion in Hematology

Volumn 23, Issue 3, 2016, Pages 253-259

  Lertkiatmongkol, Panida ^a   Liao, Danying ^a,b   Mei, Heng ^b   Hu, Yu ^b   Newman, Peter J ^a,c  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

CD31; Endothelial cell junctions; Platelet endothelial cell adhesion molecule 1; Vascular permeability

Indexed keywords

CD31 ANTIGEN;

BLOOD VESSEL PERMEABILITY; CELL JUNCTION; CELL SURVIVAL; ENDOTHELIUM CELL; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; TISSUE DISTRIBUTION; METABOLISM; PHYSIOLOGY;

ANTIGENS, CD31; ENDOTHELIAL CELLS; HUMANS;

EID: 84963651443     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0000000000000239     Document Type: Review

References (78)

1. Ohto H, Maeda H, Shibata Y, et al. A novel leukocyte differentiation antigen: Two monoclonal antibodies TM2 and TM3 define a 120-kd molecule present on neutrophils, monocytes, platelets, and activated lymphoblasts. Blood 1985; 66:873-881.
2. Goyert SM, Ferrero EM, Seremetis SV, et al. Biochemistry and expression of myelomonocytic antigens. J Immunol 1986; 137:3909-3914.
3. Lyons AB, Cooper SJ, Cole SR, Ashman LK. Human myeloid differentiation antigens identified by monoclonal antibodies to the myelomonocytic leukemia cell line RC-2A. Pathology 1988; 20:137-146.
4. Cabanas C, Sanchez-Madrid F, Bellon T, et al. Characterization of a novel myeloid antigen regulated during differentiation of monocytic cells. Eur J Immunol 1989; 19:1373-1378.
5. Van Mourik JA, Leeksma OC, Reinders JH, et al. Vascular endothelial cells synthesize a plasma membrane protein indistinguishable from platelet membrane glycoprotein IIa. J Biol Chem 1985; 260:11300-11306.
6. Giltay JC, Brinkman HJ, Modderman PW, et al. Human vascular endothelial cells express a membrane protein complex immunochemically indistinguishable from the platelet VLA-2 (glycoprotein Ia-IIa) complex. Blood 1989; 73:1235-1241.
7. Muller WA, Ratti CM, McDonnell SL, Cohn ZA. A human endothelial cellrestricted externally disposed plasmalemmal protein enriched in intercellular junctions. J Exp Med 1989; 170:399-414.
8. Albelda SM, Oliver PD, Romer LH, Buck CA. EndoCAM: a novel endothelial cell-cell adhesion molecule. J Cell Biol 1990; 110:1227-1237.
9. Newman PJ, Berndt MC, Gorski J, et al. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 1990; 247:1219-1222.
10. Stockinger H, Gadd SJ, Eher R, et al. Molecular characterization and functional analysis of the leukocyte surface protein CD31. J Immunol 1990; 145:3889-3897.
11. Simmons DL, Walker C, Power C, Pigott R. Molecular cloning of CD31, a putative intercellular adhesion molecule closely related to carcinoembryonic antigen. J Exp Med 1990; 171:2147-2152.
12. Newman PJ, Newman DK. Chapter 15. PECAM-1 In Platelets (Third Edition) (A.D. Michelson, editor) Elsevier/Academic Press, San Diego, CA, pp. 283-293, 2013.
13. Ilan N, Madri JA. PECAM-1: old friend, new partners. Curr Opin Cell Biol 2003; 15:515-524.
14. Newman PJ, Newman DK. Signal transduction pathways mediated by PECAM-1. New roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol 2003; 23:953-964.
15. Woodfin A, Voisin MB, Nourshargh S. PECAM-1: a multifunctional molecule in inflammation and vascular biology. Arterioscler Thromb Vasc Biol 2007; 27:2514-2523.
16. Privratsky JR, Newman DK, Newman PJ. PECAM-1: conflicts of interest in inflammation. Life Sci 2010; 87:69-82.
17. Paddock C, Zhou D, Lertkiatmongkol P, et al. Structural basis for PECAM-1 homophilic binding. Blood 2016; 127:1052-1061.
18. Paddock C, Lytle BL, Peterson FC, et al. Residues within a lipid-associated segment of the PECAM-1 cytoplasmic domain are susceptible to inducible, sequential phosphorylation. Blood 2011; 117:6012-6023.
19. Newton JP, Hunter AP, Simmons DL, et al. CD31 (PECAM-1) exists as a dimer and is heavily N-glycosylated. Biochem Biophys Res Commun 1999; 261:283-291.
20. Tzima E, Irani-Tehrani M, Kiosses WB, et al. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 2005; 437:426-431.
21. Collins C, Guilluy C, Welch C, et al. Localized tensional forces on PECAM-1 elicit a global mechanotransduction response via the integrin-RhoA pathway. Curr Biol 2012; 22:2087-2094.
22. Conway DE, Breckenridge MT, Hinde E, et al. Fluid shear stress on endothelial cells modulates mechanical tension across VE-cadherin and PECAM-1. Curr Biol 2013; 23:1024-1030.
23. Barry AK, Wang N, Leckband DE. Local VE-cadherin mechanotransduction triggers long-ranged remodeling of endothelial monolayers. J Cell Sci 2015; 128:1341-1351.
24. Jackson DE, Loo RO, Holyst MT, Newman PJ. Identification and characterization of functional cation coordination sites in platelet endothelial cell adhesion molecule-1. Biochemistry 1997; 36:9395-9404.
25. Sun Q-H, DeLisser HM, Zukowski MM, et al. Individually distinct Ig homology domains in PECAM-1 regulate homophilic binding and modulate receptor affinity. J Biol Chem 1996; 271:11090-11098.
26. Mei H, Campbell JM, Paddock CM, et al. Regulation of endothelial cell barrier function by antibody-driven affinity modulation of platelet endothelial cell adhesion molecule-1 (PECAM-1). J Biol Chem 2014; 289:20836-20844.
27. Baldwin HS, Shen HM, Yan H-C, et al. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during early mammalian cardiovascular development. Development 1994; 120:2539-2553.
28. Sheibani N, Sorenson CM, Frazier WA. Tissue specific expression of alternatively spliced murine PECAM-1 isoforms. Dev Dyn 1999; 214:44-54.
29. Wang Y, Su X, Sorenson CM, Sheibani N. Modulation of PECAM-1 expression and alternative splicing during differentiation and activation of hematopoietic cells. J Cell Biochem 2003; 88:1012-1024.
30. Kondo S, Scheef EA, Sheibani N, Sorenson CM. PECAM-1 isoform-specific regulation of kidney endothelial cell migration and capillary morphogenesis. Am J Physiol Cell Physiol 2007; 292:C2070-C2083.
31. Bergom C, Paddock C, Gao C, et al. An alternatively spliced isoform of PECAM-1 is expressed at high levels in human and murine tissues, and suggests a novel role for the C-terminus of PECAM-1 in cytoprotective signaling. J Cell Sci 2008; 121:1235-1242.
32. Park S, Sorenson CM, Sheibani N. PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesis. Clin Sci (Lond) 2015; 129:217-234.
33. Tourdot BE, Brenner MK, Keough KC, et al. Immunoreceptor tyrosine-based inhibitory motif (ITIM)-mediated inhibitory signaling is regulated by sequential phosphorylation mediated by distinct nonreceptor tyrosine kinases: a case study involving PECAM-1. Biochemistry 2013; 52:2597-2608.
34. Jackson DE, Ward CM, Wang R, Newman PJ. The protein-tyrosine phosphatase SHP-2 binds PECAM-1 and forms a distinct signaling complex during platelet aggregation. Evidence for a mechanistic link between PECAM-1 and integrin-mediated cellular signaling. J Biol Chem 1997; 272:6986-6993.
35. Newman PJ. Switched at birth: a new family for PECAM-1. J Clin Invest 1999; 103:5-9.
36. Masuda M, Osawa M, Shigematsu H, et al. Platelet endothelial cell adhesion molecule-1 is a major SH-PTP2 binding protein in vascular endothelial cells. Febs Lett 1997; 408:331-336.
37. Maas M, Wang R, Paddock C, et al. Reactive oxygen species induce reversible PECAM-1 tyrosine phosphorylation and SHP-2 binding. Am J Physiol Heart Circ Physiol 2003; 285:H2336-H2344.
38. Sun J, Paddock C, Shubert J, et al. Contributions of the extracellular and cytoplasmic domains of platelet-endothelial cell adhesion molecule-1 (PECAM-1/CD31) in regulating cell-cell localization. J Cell Sci 2000; 113:1459-1469.
39. Muller WA, Weigl SA, Deng X, Phillips DM. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993; 178:449-460.
40. Sun J, Williams J, Yan H-C, et al. Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) homophilic adhesion is mediated by immunoglobulin-like domains 1 and 2 and depends on the cytoplasmic domain and the level of surface expression. J Biol Chem 1996; 271:18561-18570.
41. Newton JP, Buckley CD, Jones EY, Simmons DL. Residues on both faces of the first immunoglobulin fold contribute to homophilic binding sites on PECAM-1/CD31. JBC 1997; 272:20555-20563.
42. Privratsky JR, Paddock CM, Florey O, et al. Relative contribution of PECAM-1 adhesion and signaling to the maintenance of vascular integrity. J Cell Sci 2011; 124:1477-1485.
43. Privratsky JR, Newman PJ. PECAM-1: regulator of endothelial junctional integrity. Cell Tissue Res 2014; 355:607-619.
44. Kitazume S, Imamaki R, Ogawa K, et al. a2,6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiapoptotic signaling. J Biol Chem 2010; 285:6515-6521.
45. Varki A, Angata T. Siglecs: the major subfamily of I-type lectins. Glycobiology 2006; 16:1R-27R.
46. Kitazume S, Imamaki R, Kurimoto A, et al. Interaction of platelet endothelial cell adhesion molecule (PECAM) with alpha2,6-sialylated glycan regulates its cell surface residency and antiapoptotic role. J Biol Chem 2014; 289:27604-27613.
47. Lee C, Liu A, Miranda-Ribera A, et al. NEU1 sialidase regulates the sialylation state of CD31 and disrupts CD31-driven capillary-like tube formation in human lung microvascular endothelia. J Biol Chem 2014; 289:9121-9135.
48. Lertkiatmongkol P, Paddock C, Newman PJ. Species-specific roles for α2,3-and α2,6-linked sialic acid residues in PECAM-1-mediated homophilic interactions. Blood 2015; 126:3450a.
49. Sheibani N, Newman PJ, Frazier WA. Thrombospondin-1, a natural inhibitor of angiogenesis, regulates Platelet-Endothelial Cell Adhesion Molecule-1 expression and endothelial cell morphogenesis. Mol Biol Cell 1997; 8:1329-1341.
50. DeLisser HM, Christofidou-Solomidou M, Strieter RM, et al. Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol 1997; 151:671-677.
51. Matsumura T, Wolff K, Petzelbauer P. Endothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin. J Immunol 1997; 158:3408-3416.
52. Yang S, Graham J, Kahn JW, et al. Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels. Am J Pathol 1999; 155:887-895.
53. Zhou Z, Christofidou-Solomidou M, Garlanda C, DeLisser HM. Antibody against murine PECAM-1 inhibits tumor angiogenesis in mice. Angiogenesis 1999; 3:181-188.
54. Cao G, O'Brien CD, Zhou Z, et al. Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration. Am J Physiol Cell Physiol 2002; 282:C1181-C1190.
55. Cao G, Fehrenbach ML, Williams JT, et al. Angiogenesis in platelet endothelial cell adhesion molecule-1-null mice. Am J Pathol 2009; 175:903-915.
56. O'Brien CD, Cao G, Makrigiannakis A. DeLisser HM: Role of immunoreceptor tyrosine-based inhibitory motifs of PECAM-1 in PECAM-1-dependent cell migration. Am J Physiol Cell Physiol 2004; 287:C1103-C1113.
57. Zhu JX, Cao G, Williams JT, Delisser HM. SHP-2 phosphatase activity is required for PECAM-1-dependent cell motility. Am J Physiol Cell Physiol 2010; 299:C854-865.
58. Schoenwaelder SM, Petch LA, Williamson D, et al. The protein tyrosine phosphatase Shp-2 regulates RhoA activity. Curr Biol 2000; 10:1523-1526.
59. Gratzinger D, Canosa S, Engelhardt B, Madri JA. Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho. Faseb J 2003; 17:1458-1469.
60. Winn RK, Harlan JM. The role of endothelial cell apoptosis in inflammatory and immune diseases. J Thromb Haemost 2005; 3:1815-1824.
61. Bird IN, Taylor V, Newton JP, et al. Homophilic PECAM-1(CD31) interactions prevent endothelial cell apoptosis but do not support cell spreading or migration. J Cell Sci 1999; 112:1989-1997.
62. Noble KE, Wickremasinghe RG, DeCornet C, et al. Monocytes stimulate expression of the Bcl-2 family member, A1, in endothelial cells and confer protection against apoptosis. J Immunol 1999; 162:1376-1383.
63. Evans PC, Taylor ER, Kilshaw PJ. Signaling through CD31 protects endothelial cells from apoptosis. Transplantation 2001; 71:457-460.
64. Gao C, Sun W, Christofidou-Solomidou M, et al. PECAM-1 functions as a specific and potent inhibitor of mitochondrial-dependent apoptosis. Blood 2003; 102:169-179.
65. Bergom C, Goel R, Paddock C, et al. The cell-adhesion and signaling molecule PECAM-1 is a molecular mediator of resistance to genotoxic chemotherapy. Cancer Biol Ther 2006; 5:1699-1707.
66. Cheung K, Ma L, Wang G, et al. CD31 signals confer immune privilege to the vascular endothelium. Proc Natl Acad Sci U S A 2015; 112:E5815-5824.
67. Reitsma S, Slaaf DW, Vink H, et al. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch 2007; 454:345-359.
68. Schnitzer JE, Oh P, McIntosh DP. Role of GTP hydrolysis in fission of caveolae directly from plasma membranes. Science 1996; 274:239-242.
69. Dejana E. Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol 2004; 5:261-270.
70. Wolburg H, Lippoldt A. Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul Pharmacol 2002; 38:323-337.
71. Dejana E. Endothelial adherens junctions: implications in the control of vascular permeability and angiogenesis. J Clin Invest 1996; 100:S7-S10.
72. Corada M, Mariotti M, Thurston G, et al. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci U S A 1999; 96:9815-9820.
73. Ayalon O, Sabanai H, Lampugnani MG, et al. Spatial and temporal relationships between cadherins and PECAM-1 in cell-cell junctions of human endothelial cells. J Cell Biol 1994; 126:247-258.
74. Ferrero E, Ferrero ME, Pardi R, Zocchi MR. The platelet endothelial cell adhesion molecule-1 (PECAM1) contributes to endothelial barrier function. Febs Lett 1995; 374:323-326.
75. Graesser D, Solowiej A, Bruckner M, et al. Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J Clin Invest 2002; 109:383-392.
76. Maas M, Stapleton M, Bergom C, et al. Endothelial cell PECAM-1 confers protection against endotoxic shock. Am J Physiol Heart Circ Physiol 2005; 288:H159-H164.
77. Carrithers M, Tandon S, Canosa S, et al. Enhanced susceptibility to endotoxic shock and impaired STAT3 signaling in CD31-deficient mice. Am J Pathol 2005; 166:185-196.
78. Mahooti S, Graesser D, Patil S, et al. PECAM-1 (CD31) expression modulates bleeding time in vivo. Am J Pathol 2000; 157:75-81.